Lars Erik Vølund Kristensen

Lars Erik Vølund Kristensen

Clinical Professor


Publication year:
All
1 - 10 out of 110Page size: 10
  1. 2024
  2. Published

    Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients

    Skougaard, M., Søndergaard, M. F., Ditlev, S. B. & Kristensen, Lars Erik Vølund, 2024, In: International Journal of Molecular Sciences. 25, 5, 15 p., 3002.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2023
  4. E-pub ahead of print

    Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: A Danish population-based cohort study

    Hansen, R. L., Jørgensen, T. S., Egeberg, Alexander, Rosenø, N. A. L., Skougaard, M., Stisen, Z. R., Dreyer, L. & Kristensen, Lars Erik Vølund, 2023, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

    Kristensen, Lars Erik Vølund, Strober, B., Poddubnyy, D., Leung, Y., Jo, H., Kwok, K., Vranic, I., Fleishaker, D. L., Fallon, L., Yndestad, A. & Gladman, D. D., 2023, In: Therapeutic Advances in Musculoskeletal Disease. 15, 17 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study

    Harboe, Z. B., Roed, C., Holler, J. G., Khan, F. I., Abdulrahman, A. N. A., Mulverstedt, S. L., Lindgaard-Jensen, B., Bertelsen, B. B., Søborg, C., Nielsen, T. L., Hansen, L. V., Madsen, B. L., Browatzki, A., Eiberg, M., Bernhard, P. H., Pedersen, E. M. J., Egelund, G. B., Dungu, A. M., Sejdic, A., Mathiesen, I. H. M. & 56 others, Jespersen, N. Z., Petersen, P. T., Nielsen, L., Jepsen, M. P. G., Pedersen, T. I., Eriksson, R., Seitz-Rasmussen, H. E. S., Bestle, Morten Heiberg, Andersen, H., Skram, U., Skøtt, M. R., Altaraihi, S., Sivapalan, P., Jensen , Jens-Ulrik Stæhr , Bagge, K., Jørgensen, K. M., Knudsen, M. J. S., Leineweber, T., Schneider, Uffe Vest, Ahlstrom, M. G., Rytter, S., Le Dous, N., Ravn, P., Reiter, N., Podlekareva, D., Knudsen, A., Johnsen, Stine, Kristensen, Lars Erik Vølund, Leding, C., Hertz, B. B., Benfield, Thomas, Kirk, Ole, Holler, J. G., Ostrowski, Sisse Rye, Sigurdsson, S. T., Perner, Anders, Kirkby, N., Pedersen, M. S., Van Wijhe, M., Simonsen, L., Bager, P. M., Krause, T. G., Voldstedlund, M., Christiansen, L. E., Stegger, M., Cohen, A., Fonager, J., Fomsgaard, A., Legarth, R., Rasmussen, M., Gubbels, S., Wohlfahrt, J., Lillebaek, Troels, Johannesen, C. K., Van Wijhe, M. & Fischer, Thea Kølsen, 2023, In: PLoS ONE. 18, 4 , 15 p., e0282806.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors

    Skougaard, M., Ditlev, S. B., Søndergaard, M. F. & Kristensen, Lars Erik Vølund, 2023, In: International Journal of Molecular Sciences. 24, 7, 16 p., 6343.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study

    Kristensen, Lars Erik Vølund, Keiserman, M., Papp, K., Mccasland, L., White, D., Lu, W., Soliman, A. M., Eldred, A., Barcomb, L. & Behrens, F., 2023, In: Rheumatology (United Kingdom). 62, 6, p. 2113-2121 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures

    Skougaard, M., Stisen, Z. R., Jørgensen, T. S., Egeberg, Alexander, Hansen, R. L., Perez-Chada, L. M., Mogensen, Mette, Merola, J. F., Gerwien, J. G. & Kristensen, Lars Erik Vølund, 2023, In: Scandinavian Journal of Rheumatology. 52, 3, p. 259-267

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1

    Kristensen, Lars Erik Vølund, Soliman, A. M., Papp, K., White, D., Barcomb, L., Lu, W., Eldred, A. & Behrens, F., 2023, In: Rheumatology (Oxford, England). 62, 2, p. 629-637 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: A Danish population-based cohort study

    Petersen, M. B., Hansen, R. L., Egeberg, Alexander, Jørgensen, T. S., Merola, J. F., Coates, L. C. & Kristensen, Lars Erik Vølund, 2023, In: Rheumatology Advances in Practice. 7, 2, rkad035.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. E-pub ahead of print

    Tolerability and comparative effectiveness of TNF-, IL-17-, and IL-23(p19) inhibitors in psoriatic arthritis: A target trial emulation study

    Stisen, Z. R., Nielsen, S. M., Skougaard, M., Mogensen, Mette, Jørgensen, T. S., Dreyer, L., de Wit, M., Christensen, R. & Kristensen, Lars Erik Vølund, 2023, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 164256855